Lazard Asset Management LLC Fibrogen Inc Transaction History

Lazard Asset Management LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.89 - $2.36 $3,673 - $9,739	4,127 New	4,127 $3,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $45,074 - $71,158	2,826 New	2,826 $52,000
Q2 2022 Aug 09, 2022	BUY	$7.94 - $12.96 $44,718 - $72,990	5,632 New	5,632 $59,000
Q1 2022 May 13, 2022	SELL	$12.02 - $16.79 $62,311 - $87,039	-5,184 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$9.93 - $15.39 $415,709 - $644,286	-41,864 Reduced 88.98%	5,184 $73,000
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $478,948 - $1.25 Million	47,048 New	47,048 $480,000
Q2 2021 Aug 12, 2021	SELL	$18.57 - $35.68 $32,534 - $62,511	-1,752 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$31.0 - $55.72 $54,312 - $97,621	1,752 New	1,752 $60,000
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $89,519 - $100,646	-2,212 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$32.57 - $42.83 $72,044 - $94,739	2,212 New	2,212 $89,000
Q1 2020 May 14, 2020	SELL	$23.3 - $45.96 $20,084 - $39,617	-862 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$34.58 - $48.06 $12,517 - $17,397	362 Added 72.4%	862 $36,000
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $18,490 - $24,225	500 New	500 $18,000
Q1 2018 May 14, 2018	SELL	$45.35 - $61.65 $403,615 - $548,685	-8,900 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$41.95 - $60.1 $7.15 Million - $10.2 Million	-170,390 Reduced 95.04%	8,900 $421,000
Q2 2015 Jul 08, 2019	BUY	N/A	5,875 Added 3.39%	179,290 $4.21 Million
Q4 2014 Aug 29, 2019	BUY	N/A	173,415	173,415 $4.74 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.